Bio-Techne
TECH
#1989
Rank
ยฃ7.21 B
Marketcap
ยฃ46.30
Share price
-2.93%
Change (1 day)
-19.70%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.29 Billion

According to Bio-Techne's latest financial reports the company's total debt is ยฃ0.29 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-06-30ยฃ0.33 B-7.32%
2023-06-30ยฃ0.35 B33.52%
2022-06-30ยฃ0.26 B-11.86%
2021-06-30ยฃ0.30 B-13.09%
2020-06-30ยฃ0.34 B-12.07%
2019-06-30ยฃ0.39 B55.05%
2018-06-30ยฃ0.25 B-2.89%
2017-06-30ยฃ0.26 B269.8%
2016-06-30ยฃ71.46 M45.56%
2015-06-30ยฃ49.1 M548.93%
2014-06-30ยฃ7.56 M
2006-06-30ยฃ7.34 M-11.12%
2005-06-30ยฃ8.26 M-5.15%
2004-06-30ยฃ8.71 M-15.95%
2003-06-30ยฃ10.36 M-12%
2002-06-30ยฃ11.77 M-11.97%
2001-06-30ยฃ13.37 M2.41%
2000-06-30ยฃ13.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ26.78 B 8,944.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
ยฃ1.04 B 253.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
ยฃ14.51 B 4,803.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
ยฃ12.65 B 4,173.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
ยฃ1.59 B 439.25%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
ยฃ15.64 B 5,182.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
ยฃ2.25 M-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA